Tookad (padeliporfin) / Steba Biotech 
Welcome,         Profile    Billing    Logout  

7 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tookad (padeliporfin) / ImPact Biotech
2020-004494-41: This is a study that will evaluate the safety and efficacy of TOOKAD® (padeliporfin) Vascular Targeted Photodynamic Therapy (VTP) in the Treatment of Low Grade Upper Tract Urothelial Cancer (UTUC).

Not yet recruiting
3
100
Europe
TOOKAD®, [PRD5572518], Powder for solution for injection, TOOKAD®
Steba Biotech S.A., STEBA BIOTECH S.A., Steba biotech, S.A., Steba Biotech, S.A., Steba Biotech S.A., Steba Biotech, S.A., Steba biotech, S.A.
Low Grade Upper Tract Urothelial Cancer, Urinary tract cancers, Diseases [C] - Cancer [C04]
 
 
ENLIGHTED, NCT04620239: ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer () Study

Recruiting
3
100
Europe, US, RoW
padeliporfin VTP, WST11
Steba Biotech S.A., PrimeVigilance, ICON plc
Transitional Cell Cancer of Renal Pelvis and Ureter
12/24
01/29
CLIN1601 PCM204 , NCT03315754: Study of the Efficacy, Safety and Quality of Life After TOOKAD® Soluble (VTP) for Intermediate Risk Prostate Cancer.

Active, not recruiting
2
50
US
TOOKAD Soluble 4 mg/kg, WST11
Steba Biotech S.A.
Localized Prostate Cancer
11/20
11/24
NCT03617003: Treatment of Tumors in the Urinary Collecting System of the Kidney or Ureter Using a Light Activated Drug (WST11)

Active, not recruiting
1
30
US
WST11 mediated vascular targeted phototherapy (VTP), Endoscopy
Memorial Sloan Kettering Cancer Center
Upper Tract Urothelial Carcinoma
12/24
12/24
NCT05919238: Padeliporfin VTP Treatment for Unresectable Pancreatic Adenocarcinoma

Active, not recruiting
1
30
US
Padeliporfin Vascular Targeted Photodynamic (VTP) therapy, Padeliporfin VTP
Impact Biotech Ltd, Impact biotech Ltd.
Locally Advanced Unresectable Pancreatic Adenocarcinoma
05/26
10/26
NCT03133650: A Trial of a New Type of Photodynamic Therapy (VTP) in the Treatment of Patients With Cancer of the Esophagus Who Have Trouble Swallowing

Active, not recruiting
1
12
US, RoW
WST 11-mediated VTP therapy
Memorial Sloan Kettering Cancer Center, Weizmann Institute of Science, Steba Biotech S.A.
Esophagogastric Cancer, Moderate to Severe Dysphagia
02/25
02/25
NCT05918783: Padeliporfin VTP Using Robotic Assisted Bronchoscopy in Peripheral Lung Cancer

Not yet recruiting
1
36
NA
Padeliporfin Vascular Targeted Photodynamic (VTP) therapy, Padeliporfin VTP
Impact Biotech Ltd, Impact biotech Ltd.
Peripheral Lung Tumor
05/26
12/27

Download Options